Bgm Group logo

Bgm Group(NASDAQ) BGM

Market Cap$110.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-98%
5 Year-99%
1 Year-97%
1 Month+7%
$8.96
+8.74%
+0.72Today
Bgm Group last closing stock price
MetricPriceDate
Last closeUSD 8.242026-10-21
Bgm Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-13.72%USD 9.552026-10-14
1 month+7.29%USD 7.682026-09-21
3 month-5.52%USD 8.722026-07-23
Year to date-92.56%USD 110.702025-12-31
1 year-97.11%USD 285.602025-10-21
3 year-92.48%USD 109.532023-10-20
5 year-98.54%USD 566.242021-10-22
Since inception-97.7%USD 358.502025-01-08

Bgm Group Financials at a Glance

Market Cap

$110.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$74.78M

Net Income (TTM)

-$21.72M

EPS (TTM)

-$4.80

P/E Ratio

-1.71

Dividend

$0.00

Beta (Volatility)

0.41 (Low)

Price

$8.96

Volume

23,235.609

Open

$8.65

Previous Close

$8.24

Daily Range

$7.70 - $10.66

52-Week Range

$6.45 - $303.00

Estimated Earnings Date

Mar 16, 2026

BGM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bgm Group

BGM Group Ltd. operates from Chengdu, People's Republic of China, specializing in the manufacturing and supply of active pharmaceutical ingredients (APIs) and traditional Chinese medicine (TCM) derivatives. The company offers a diverse portfolio of pharmaceutical products aimed at both human and veterinary markets.

Products and Services
  • Active pharmaceutical ingredients for various medical applications
  • Traditional Chinese medicine derivatives, including licorice-based products
  • Organic fertilizers designed to enhance agricultural productivity
Growth Outlook
  • Revenue increased to $24.3 million in Q2 2026, showing strong demand
  • Gross profit margin improved to 13.8% in the latest quarter
  • Expansion into organic fertilizers aligns with growing agricultural trends
Financial Highlights
  • Net income for Q2 2026 was -$2.1 million, reflecting ongoing investment
  • Cash and cash equivalents reached $11.5 million, providing liquidity
  • Current ratio stands at 1.25, indicating solid short-term financial health
BGM Group Ltd. has established itself as a key player in the pharmaceutical and agricultural sectors. The company's focus on active pharmaceutical ingredients and traditional Chinese medicine positions it well within the growing healthcare market. Recent financial performance indicates a positive trajectory, with revenue growth and improved gross profit margins. The strategic expansion into organic fertilizers also reflects an adaptive approach to market demands. With a solid cash position and a favorable current ratio, BGM Group Ltd. demonstrates potential for future growth and stability.
AI Generated • Oct 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

471

CEO

Chen Xin

Website

www.bgm.ltd

Headquarters

Chengdu, SIC 610200, CN

BGM Financials

Key Financial Metrics (TTM)

Gross Margin

12.81%

Operating Margin

-23.42%

Net Income Margin

-44.22%

Return on Equity

-5.37%

Return on Capital

-3.20%

Return on Assets

-4.85%

Earnings Yield

-58.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$110.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

13.35M

Volume

23.24K

Avg. Volume

6.32K

Financials (TTM)

Gross Profit

$9.62M

Operating Income

-$14.14M

EBITDA

-$11.72M

Operating Cash Flow

$115.46K

Capital Expenditure

-$2.73M

Free Cash Flow

-$2.61M

Cash & ST Invst.

$11.55M

Total Debt

$1.18M

Bgm Group Performance Analysis

Bgm Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 64,855,025N/A
20232023-09-30USD 46,471,478-28.3%
20242024-09-30USD 25,097,951-46.0%
20252025-09-30USD 37,919,42551.1%
Bgm Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-09-30N/A
Q22025-03-31N/A
Q42025-09-3065.0%
Q22026-03-312.9%
Bgm Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD 4.52N/A
20232023-09-30USD -32.65N/A
20242024-09-30USD -5.99-81.7%
20252025-09-30USD -5.28-11.8%
Bgm Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-09-30N/A
Q22025-03-31N/A
Q42025-09-30-448.8%
Q22026-03-3192.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$24.30M

N/A

Gross Profit

$3.36M

N/A

Gross Margin

13.81%

N/A

Market Cap

$110.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$369.25K

N/A

Employees

298

N/A

Net Income

-$2.10M

N/A

EBITDA

$74.18K

N/A

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$11.55M

-54.5%

Total Debt

$1.18M

+1066.3%

Accounts Receivable

$11.99M

+340.3%

Inventory

$22.08M

+374.7%

Long Term Debt

$2.60K

-85.3%

Short Term Debt

$1.17M

+1311.1%

Return on Assets

-4.85%

N/A

Return on Invested Capital

-2.81%

N/A

Free Cash Flow

$1.82M

N/A

Operating Cash Flow

$2.49M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QDELQuidelOrtho Corporation
$13.93-1.07%
PRCTPROCEPT BioRobotics Corporation
$19.77+8.21%
GPCRStructure Therapeutics Inc.
$22.22+0.93%
PAHCPhibro Animal Health Corporation
$40.03+1.99%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$85.54-17.14%
NOKNokia
$8.22-11.13%
SPCXSpace Exploration Technologies
$150.09-5.79%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.18-3.23%

Questions About BGM

What is the current price of Bgm Group?

Bgm Group is trading at $8.45 per share.

What is the 52-week range for Bgm Group?

Over the past 52 weeks, Bgm Group has traded between $6.45 and $303.00.

How much debt does Bgm Group have?

As of the most recent reporting period, Bgm Group reported total debt of $1.94M.

How much cash does Bgm Group have on hand?

Bgm Group reported $9.82M in cash and cash equivalents in its most recent financial results.

What is Bgm Group’s dividend yield?

Bgm Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services